Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Frankel

Showing results (211-220 of 259) with videos related to

Pageof 26
Sort By:
Molecular Cancer Therapeutics|January 7, 2005
Diphtheria toxin-murine granulocyte-macrophage colony-stimulating factor-induced hepatotoxicity is mediated by Kupffer cellsMarlena M Westcott, Ralph J Abi-Habib, Kimberley A Cohen, et al.
Burns : Journal of the International Society for Burn Injuries|June 14, 2017
Long term mortality in critically ill burn survivorsStephanie Nitzschke, Anaeze C Offodile, Ryan P Cauley, et al.
Anti-Cancer Drugs|June 22, 2007
Recombinant prostate-specific antigen proaerolysin shows selective protease sensitivity and cell cytotoxicityRavibhushan Singh, Jeff L Browning, Ralph Abi-Habib, et al.
Frontiers in Bioscience : a Journal and Virtual Library|May 9, 2007
Lethal and edema toxins of anthrax induce distinct hemodynamic dysfunctionLinley E Watson, Jonathan Mock, Hind Lal, et al.
Translational Oncology|February 21, 2012
Recombinant human arginase toxicity in mice is reduced by citrulline supplementationJeremy P Mauldin, Ideen Zeinali, Keri Kleypas, et al.
Melanoma Research|October 12, 2014
In-vivo evaluation of human recombinant Co-arginase against A375 melanoma xenograftsVaidehi Agrawal, Jung Hee Woo, Jeremy P Mauldin, et al.
Integrative Cancer Therapies|April 25, 2019
Cancer Immune Checkpoint Inhibitor Therapy and the Gut MicrobiotaArthur E Frankel, Sachin Deshmukh, Amit Reddy, et al.
Clinical Case Reports|May 3, 2021
Response to pegylated interferon in a COVID-19-positive elderly woman with primary myelofibrosis treated with ruxolitinibArthur E Frankel, Renuka Reddy, Kayla R DeSuza, et al.
Plos One|May 24, 2007
Anthrax toxins induce shock in rats by depressed cardiac ventricular functionLinley E Watson, Shu-Ru Kuo, Khurshed Katki, et al.
British Journal of Haematology|June 20, 2014
SL-401 and SL-501, targeted therapeutics directed at the interleukin-3 receptor, inhibit the growth of leukaemic cells and stem cells in advanced phase chronic myeloid leukaemiaOlga Frolova, Juliana Benito, Chris Brooks, et al.
Pageof 26

Showing results (211-220 of 259) with videos related to

Sort By:
Pageof 26
Molecular Cancer Therapeutics|January 7, 2005
Diphtheria toxin-murine granulocyte-macrophage colony-stimulating factor-induced hepatotoxicity is mediated by Kupffer cellsMarlena M Westcott, Ralph J Abi-Habib, Kimberley A Cohen, et al.
Burns : Journal of the International Society for Burn Injuries|June 14, 2017
Long term mortality in critically ill burn survivorsStephanie Nitzschke, Anaeze C Offodile, Ryan P Cauley, et al.
Anti-Cancer Drugs|June 22, 2007
Recombinant prostate-specific antigen proaerolysin shows selective protease sensitivity and cell cytotoxicityRavibhushan Singh, Jeff L Browning, Ralph Abi-Habib, et al.
Frontiers in Bioscience : a Journal and Virtual Library|May 9, 2007
Lethal and edema toxins of anthrax induce distinct hemodynamic dysfunctionLinley E Watson, Jonathan Mock, Hind Lal, et al.
Translational Oncology|February 21, 2012
Recombinant human arginase toxicity in mice is reduced by citrulline supplementationJeremy P Mauldin, Ideen Zeinali, Keri Kleypas, et al.
Melanoma Research|October 12, 2014
In-vivo evaluation of human recombinant Co-arginase against A375 melanoma xenograftsVaidehi Agrawal, Jung Hee Woo, Jeremy P Mauldin, et al.
Integrative Cancer Therapies|April 25, 2019
Cancer Immune Checkpoint Inhibitor Therapy and the Gut MicrobiotaArthur E Frankel, Sachin Deshmukh, Amit Reddy, et al.
Clinical Case Reports|May 3, 2021
Response to pegylated interferon in a COVID-19-positive elderly woman with primary myelofibrosis treated with ruxolitinibArthur E Frankel, Renuka Reddy, Kayla R DeSuza, et al.
Plos One|May 24, 2007
Anthrax toxins induce shock in rats by depressed cardiac ventricular functionLinley E Watson, Shu-Ru Kuo, Khurshed Katki, et al.
British Journal of Haematology|June 20, 2014
SL-401 and SL-501, targeted therapeutics directed at the interleukin-3 receptor, inhibit the growth of leukaemic cells and stem cells in advanced phase chronic myeloid leukaemiaOlga Frolova, Juliana Benito, Chris Brooks, et al.
Pageof 26